The Growing Crisis of Diabetes Treatment and the Promise of Medical Tourism

Diabetes rates are surging worldwide, but a lack of resources and rising treatment costs are leaving millions without adequate care. A recent Financial Times article highlights the crisis, pointing to challenges in meeting the demand for affordable treatments and innovations like continuous glucose monitors and insulin pumps. As more patients struggle to afford care, many are turning to medical tourism for cost-effective solutions.

MEDICAL TOURISM

Dominica Evans

11/14/20241 min read

a person blood sugar testing using a gluco-meter
a person blood sugar testing using a gluco-meter

According to the World Health Organization (WHO), diabetes affects over 537 million adults globally, and by 2030, this number is expected to rise to 643 million. In the U.S., diabetic patients pay up to $4,000 annually on insulin alone, with some opting to ration their medication due to costs (American Diabetes Association).

Medical tourism is offering an alternative. In countries like Panama, specialized clinics provide diabetes treatments, including consultations and supplies, at more accessible rates. These facilities also offer orthopaedic care and sports medicine for complications associated with diabetes, such as foot issues and joint problems. Patients benefit from advanced care without the steep prices seen in the U.S.

Organizations like Panamedico are helping to bridge this gap by offering bundled services that include travel logistics, consultations, and treatments for diabetic care. Studies show that medical tourists can save 40-80% compared to the cost of similar treatments in the U.S. Not only does this alleviate financial strain, but it allows patients access to treatments that may otherwise be out of reach.

Ultimately, as treatment costs rise, medical tourism presents a viable solution for diabetic patients seeking quality care at lower costs. For further reading, check out the American Diabetes Association’s reports on treatment affordability, as well as the WHO’s latest global health report.

Read full article from the link below.

Source: Financial Times (2024) Diabetics left withoout treatment as gloobal disease doubles.